1. Home
  2. Knowledge Base
  3. References
  4. The validity of scopolamine as a pharmacological model for cognitive impairment: A review of animal behavioral studies

The validity of scopolamine as a pharmacological model for cognitive impairment: A review of animal behavioral studies

Klinkenberg I, Blokland A (2010) The validity of scopolamine as a pharmacological model for cognitive impairment: A review of animal behavioral studies. Neurosci Biobehav Rev 34(8):1307-1350. doi: 10.1016/j.neubiorev.2010.04.001

Objective: To provide an overview is given of the effects of scopolamine on animal behavior.

Summary: The most important and influential articles over the past 40 years are included in the present review. The cholinergic hypothesis of memory function as originally put forward by Bartus et al. (1982) has undergone a revision after several lesion studies were performed which used the highly specific cholinergic toxin 192 IgG-SAP (Wiley et al., 1995).

Related Products: 192-IgG-SAP (Cat. #IT-01)

See Also:

Shopping Cart
Scroll to Top